# Emphysematous gastritis: The silent storm within the stomach wall

**Authors:** Chander Shekher Aggarwal, Simran Dahiya, Smriti Kochhar, Kanishk Aggarwal, Luke Edgecombe, Toluwanimi Jeje, Rohit Jain

PMC · DOI: 10.1177/03000605251389384 · The Journal of International Medical Research · 2025-10-31

## TL;DR

Emphysematous gastritis is a rare, deadly stomach condition caused by gas-producing microbes, requiring timely diagnosis and treatment to improve survival.

## Contribution

This review provides updated insights into the diagnosis and management of emphysematous gastritis, emphasizing early medical treatment over surgery.

## Key findings

- Emphysematous gastritis has a high mortality rate (55-61%) and is caused by gas-producing bacteria and fungi.
- Computed tomography is the most effective diagnostic tool for identifying the condition.
- Early conservative treatment with antibiotics is emphasized over surgical intervention in recent studies.

## Abstract

Emphysematous gastritis is a rare, life-threatening condition characterized by inflammation of the stomach lining and gas within the gastric wall, with a mortality rate ranging from 55% to 61%. Emphysematous gastritis is caused by gas-producing bacteria and fungi that can infect both gastric and bowel walls. Risk factors include diabetes, corticosteroid use, prolonged nonsteroidal anti-inflammatory drug use, neoplasia, recent abdominal surgery, and other conditions that compromise immune function. Emphysematous gastritis can present with nonspecific symptoms such as abdominal pain, nausea, vomiting, diarrhea, and fever; however, severe manifestations such as hematemesis and sepsis may also occur. Symptoms alone are insufficient for establishing a definitive diagnosis; computed tomography is the most effective imaging modality to identify characteristic findings. Management typically involves conservative treatment with bowel rest, hydration, and intravenous antibiotics. Surgical intervention may be required in cases of clinical deterioration; however, its role remains controversial. Recent studies have questioned the necessity of surgery, emphasizing early medical management to improve outcomes. This narrative review aims to provide an overview of emphysematous gastritis, focusing on its pathophysiology, clinical features, diagnostic methods, and treatment strategies. It highlights the significance of timely intervention to improve survival and reduce the high mortality associated with this rare condition.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015)

## Full-text entities

- **Diseases:** vomiting (MESH:D014839), hematemesis (MESH:D006396), abdominal pain (MESH:D015746), diarrhea (MESH:D003967), inflammation (MESH:D007249), fever (MESH:D005334), nausea (MESH:D009325), neoplasia (MESH:D009369), sepsis (MESH:D018805), Emphysematous gastritis (MESH:D005756), diabetes (MESH:D003920)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12579736/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12579736/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12579736/full.md

---
Source: https://tomesphere.com/paper/PMC12579736